Aurora Cannabis (ACB) Cash from Operations Growth (1y) (2018 - 2026)
Aurora Cannabis (ACB) Cash from Operations Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.15 Bn | 87.28 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.85 Bn | 32.11 Bn | 1.97 Bn | 61.90% |
| 3 | Zoetis | 32.52 Bn | 30.58 Bn | 1.62 Bn | -22.14% |
| 4 | Takeda Pharmaceutical | 27.53 Bn | 23.47 Bn | 4.39 Bn | 8.20% |
| 5 | United Therapeutics | 23.21 Bn | 21.06 Bn | 648.10 Mn | 0.46% |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - | - |
| 7 | Viatris | 20.30 Bn | 18.50 Bn | 1.16 Bn | -27.49% |
| 8 | Neurocrine Biosciences | 17.74 Bn | 16.42 Bn | 800.70 Mn | 125.00% |
| 9 | Elanco Animal Health | 12.59 Bn | 12.16 Bn | 785.00 Mn | 425.00% |
| 10 | Aurora Cannabis | 155.11 Mn | 69.87 Mn | 21.72 Mn | -64.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -64.34% |
| Dec 31, 2025 | -2.69% |
| Mar 31, 2025 | 143.16% |
| Dec 31, 2024 | 633.92% |
| Sep 30, 2024 | 20.79% |
| Dec 31, 2023 | 95.57% |
| Sep 30, 2023 | 48.02% |
| Dec 31, 2022 | -740.21% |
| Sep 30, 2022 | -79.16% |
| Jun 30, 2022 | -232.25% |
| Mar 31, 2022 | 32.08% |
| Dec 31, 2021 | 78.89% |
| Sep 30, 2021 | 69.63% |
| Jun 30, 2021 | 140.69% |
| Mar 31, 2021 | -3.47% |
| Dec 31, 2020 | 51.78% |
| Sep 30, 2020 | -13.27% |
| Jun 30, 2020 | 86.32% |
| Mar 31, 2020 | -206.46% |
| Dec 31, 2019 | -310.82% |